Tau Biomarkers in Late-onset Psychosis (LOP)
Abroad (travel likely)Recruiting
Conditions
Late Onset Schizophrenia · Delusional Disorder (Late Onset)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Feinstein Institutes for Medical Research, Manhasset, New York, United States
Study leads
Jeremy Koppel, MD
Principal Investigator
Northwell Health